Upregulated microRNA-193a-3p is responsible for cisplatin resistance in CD44(+) gastric cancer cells
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Upregulated microRNA-193a-3p is responsible for cisplatin resistance in CD44(+) gastric cancer cells
Authors
Keywords
-
Journal
CANCER SCIENCE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-11-29
DOI
10.1111/cas.13894
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activated Integrated Stress Response Induced by Salubrinal Promotes Cisplatin Resistance in Human Gastric Cancer Cells via Enhanced xCT Expression and Glutathione Biosynthesis
- (2018) Sheng-Fan Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Gastric adenocarcinoma
- (2017) Jaffer A. Ajani et al. Nature Reviews Disease Primers
- The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer
- (2016) Ranjeeta Thapa et al. Stem Cells International
- miR-106b modulates cancer stem cell characteristics through TGF-β/Smad signaling in CD44-positive gastric cancer cells
- (2014) Dayeon Yu et al. LABORATORY INVESTIGATION
- DNA Methylation-regulated miR-193a-3p Dictates Resistance of Hepatocellular Carcinoma to 5-Fluorouracil via Repression of SRSF2 Expression
- (2011) Kelong Ma et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia
- (2011) X-N Gao et al. ONCOGENE
- Acetylation and phosphorylation of SRSF2 control cell fate decision in response to cisplatin
- (2010) Valerie Edmond et al. EMBO JOURNAL
- MicroRNA regulation of core apoptosis pathways in cancer
- (2010) Raquel T. Lima et al. EUROPEAN JOURNAL OF CANCER
- Resistance May Not Be Futile: microRNA Biomarkers for Chemoresistance and Potential Therapeutics
- (2010) K. E. Allen et al. MOLECULAR CANCER THERAPEUTICS
- MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways
- (2010) X Rao et al. ONCOGENE
- The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo
- (2010) G Merdzhanova et al. ONCOGENE
- Origins and Mechanisms of miRNAs and siRNAs
- (2009) Richard W. Carthew et al. CELL
- Differential expression of miRNA patterns in renal cell carcinoma and nontumorous tissues
- (2009) Zhengjun Yi et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Control of mitochondrial apoptosis by the Bcl-2 family
- (2009) J. K. Brunelle et al. JOURNAL OF CELL SCIENCE
- E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SC35
- (2008) G Merdzhanova et al. CELL DEATH AND DIFFERENTIATION
- miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells
- (2008) Lin Xia et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1
- (2008) Tyler E. Miller et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now